Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25035080 |
CA |
66 | 1 |
Arrhythmia, Asthma, Atrial fibrillation, Blood glucose increased, Thrombosis, |
||||
OMALIZUMAB, AMLODIPINE, AMLODIPINE, ROFLUMILAST, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 502 | 25035314 |
US |
58 | 1 |
Accidental overdose, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 503 | 25035315 |
US |
59 | 1 |
Blood glucose increased, Product storage error, Urinary tract infection, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 504 | 25035560 |
US |
69 | 2 |
Disorientation, Gait inability, Blood glucose increased, Nausea, |
||||
INSULIN LISPRO, |
||||
| 505 | 25035913 |
US |
2 | |
Blood glucose increased, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 506 | 25036032 |
US |
63 | 2 |
Product dose omission issue, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, CANDESARTAN, |
||||
| 507 | 25036287 |
US |
2 | |
Blood glucose increased, Visual impairment, Memory impairment, Intentional product misuse, |
||||
INSULIN LISPRO, |
||||
| 508 | 25036727 |
GB |
64 | 2 |
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 509 | 25036834 |
US |
1 | |
Blood glucose increased, Memory impairment, |
||||
INSULIN LISPRO, |
||||
| 510 | 25036847 |
CN |
65 | 2 |
Blood glucose increased, Cataract, Hypoacusis, Injection site pain, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 511 | 25036853 |
US |
53 | 1 |
Blood glucose increased, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN HUMAN, |
||||
| 512 | 25036858 |
US |
39 | 1 |
Loss of consciousness, Road traffic accident, Pyrexia, Pruritus, Blood glucose abnormal, Urticaria, Drug ineffective, Blood glucose increased, Tremor, |
||||
INSULIN LISPRO, INSULIN HUMAN, INSULIN HUMAN, INSULIN GLARGINE, |
||||
| 513 | 25036877 |
US |
88 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 514 | 25037236 |
PK |
53 | 2 |
Lower respiratory tract infection, Breast cancer recurrent, Metastasis, Blood glucose increased, Back pain, Osteopenia, Sciatica, Pain in extremity, Influenza, Tooth disorder, Rhinitis allergic, Wound, Decubitus ulcer, Respiratory tract infection, Glycosylated haemoglobin increased, Inflammation, Product prescribing error, Cough, |
||||
PALBOCICLIB, LETROZOLE, LETROZOLE, ZOLEDRONIC ACID, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MONTELUKAST SODIUM, MONTELUKAST, AMOXICILLIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, KENALOG, |
||||
| 515 | 25037685 |
US |
11 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 516 | 25037767 |
US |
2 | |
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 517 | 25038811 |
US |
63 | 2 |
Suicidal ideation, Depression, Blood glucose increased, Blood glucose decreased, Product quality issue, |
||||
INSULIN ASPART, INSULIN GLARGINE, INSULIN DEGLUDEC, |
||||
| 518 | 25029137 |
US |
70 | 2 |
Vulvovaginal pruritus, Skin hypertrophy, Blood glucose increased, Peripheral coldness, Vulvovaginal burning sensation, |
||||
EMPAGLIFLOZIN, |
||||
| 519 | 25029245 |
US |
2 | |
Haemorrhoid operation, Large intestine polyp, Colectomy, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 520 | 25029268 |
US |
66 | 1 |
Brachytherapy to prostate, Cataract operation, Hearing aid user, Urinary incontinence, Anal incontinence, Asthenia, Diarrhoea, Blood glucose increased, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, CAFFEINE, |
||||
| 521 | 25029291 |
US |
51 | 2 |
COVID-19, Diabetic complication, Seizure, Respiratory tract infection, Chronic kidney disease, Dehydration, Blood glucose increased, COVID-19, |
||||
INSULIN ASPART, INSULIN DEGLUDEC, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 522 | 25029314 |
CA |
79 | 1 |
Atrial flutter, Atrial fibrillation, Injection site pain, Needle issue, Hip fracture, Body temperature decreased, Epistaxis, Injection site haemorrhage, Stress, Anaemia, Fatigue, Contusion, Red blood cell count decreased, Haemoglobin decreased, Blood glucose increased, Rotator cuff syndrome, Blood pressure diastolic decreased, Limb injury, Arrhythmia, Neoplasm progression, Injection site swelling, Skin discolouration, Fall, Blood pressure systolic increased, Internal haemorrhage, Dizziness, Bradycardia, Arthralgia, Heart rate decreased, Sleep disorder, Pain, Dyspnoea, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, RAMIPRIL, RAMIPRIL, ATORVASTATIN CALCIUM, RIVAROXABAN, RIVAROXABAN, FINASTERIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SITAGLIPTIN, |
||||
| 523 | 25029899 |
US |
53 | 1 |
Visual impairment, Incorrect dose administered, Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 524 | 25029989 |
US |
67 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 525 | 25030079 |
US |
80 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 526 | 25030085 |
US |
68 | 1 |
Blood glucose increased, Injection site bruising, Injection site mass, Injection site rash, Injection site erythema, |
||||
INSULIN HUMAN, |
||||
| 527 | 25030152 |
DE |
||
Nephrotic syndrome, Chronic kidney disease, Glomerulonephritis, Blood albumin decreased, Lipoprotein (a) increased, Chronic hepatitis C, Blood creatine phosphokinase increased, Disease recurrence, Protein total increased, Vitamin D deficiency, Renal hypertension, Drug intolerance, Low density lipoprotein increased, Reticulocyte count increased, Blood uric acid increased, Protein urine present, Urine protein/creatinine ratio increased, Blood creatine phosphokinase MB increased, Coronavirus infection, Proteinuria, Blood glucose increased, |
||||
ROSUVASTATIN, ROSUVASTATIN, INCLISIRAN, APIXABAN, BEMPEDOIC ACID, TORSEMIDE, SPIRONOLACTONE, DAPAGLIFLOZIN, |
||||
| 528 | 25030246 |
US |
2 | |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 529 | 25030601 |
US |
62 | 1 |
Blood glucose increased, Injection site pain, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 530 | 25030607 |
US |
65 | 2 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN HUMAN, |
||||
| 531 | 25030791 |
US |
60 | 2 |
Blood pressure diastolic decreased, Gait disturbance, Headache, Fall, Blood glucose increased, Hypotension, |
||||
EVOLOCUMAB, PREDNISONE, |
||||
| 532 | 25030873 |
US |
66 | 1 |
Hypoacusis, Blood glucose increased, |
||||
INSULIN LISPRO, DULAGLUTIDE, |
||||
| 533 | 25031452 |
US |
74 | 1 |
Neoplasm malignant, Fatigue, Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE, APIXABAN, |
||||
| 534 | 25031630 |
US |
40 | |
Increased appetite, Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
DULAGLUTIDE, EMPAGLIFLOZIN, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 535 | 25032020 |
68 | 2 | |
Thirst, Dry mouth, Blood glucose increased, Vision blurred, Visual impairment, Fatigue, Decreased appetite, Pollakiuria, Gait disturbance, Swelling face, Pain in jaw, Frequent bowel movements, Pyrexia, Dizziness, Arthralgia, Constipation, Acute kidney injury, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, AMOXICILLIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LISINOPRIL, SITAGLIPTIN, FENOFIBRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, |
||||
| 536 | 25032804 |
SE |
81 | 2 |
Drug dependence, Blood glucose increased, Malaise, Constipation, |
||||
SITAGLIPTIN, SITAGLIPTIN, |
||||
| 537 | 25032877 |
US |
65 | 2 |
Thirst, Headache, Dizziness, Blood glucose increased, Visual impairment, Abdominal pain upper, Vomiting, Accidental underdose, |
||||
INSULIN LISPRO, DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN DETEMIR, |
||||
| 538 | 25032964 |
US |
65 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 539 | 25033073 |
CA |
59 | 1 |
Arteriosclerosis coronary artery, 5-hydroxyindolacetic acid increased, Aspartate aminotransferase increased, Blood glucose increased, Blood mercury abnormal, Blood potassium decreased, Blood pressure systolic increased, Diarrhoea, Gamma-glutamyltransferase increased, Glycosylated haemoglobin increased, Haematocrit decreased, Haemoglobin decreased, Hepatic neoplasm, Low density lipoprotein decreased, Nausea, Neoplasm, Pruritus, Platelet count decreased, Red blood cell count decreased, Syncope, Urticaria, Vomiting, Inappropriate schedule of product administration, Expired product administered, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, GLYBURIDE, GLYBURIDE, GLYBURIDE, GLYBURIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, QUINAPRIL HYDROCHLORIDE, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, |
||||
| 540 | 25033085 |
US |
40 | 2 |
Blood glucose increased, Muscle spasms, Hyperhidrosis, Hypersensitivity, Injection site urticaria, |
||||
LIRAGLUTIDE, |
||||
| 541 | 25033146 |
US |
2 | |
Hypertension, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
LIRAGLUTIDE, |
||||
| 542 | 25033217 |
US |
55 | 1 |
Myocardial infarction, Acquired cardiac septal defect, Pasteurella infection, Blood glucose increased, Product dose omission issue, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, |
||||
| 543 | 25033234 |
ES |
52 | 1 |
Cholelithiasis, Pancreatitis necrotising, Multiple organ dysfunction syndrome, Abdominal compartment syndrome, Cholangitis, Haematocrit increased, Lymphocyte count decreased, Eosinophil count decreased, Blood calcium decreased, Blood urea increased, Blood bilirubin increased, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, ENALAPRIL MALEATE, ENALAPRIL, |
||||
| 544 | 25033315 |
RU |
31 | 2 |
Blood glucose increased, Drug ineffective, Hypoglycaemia, |
||||
INSULIN LISPRO, INSULIN GLULISINE, INSULIN ASPART, |
||||
| 545 | 25033472 |
US |
82 | 1 |
Blood glucose increased, Device difficult to use, |
||||
INSULIN GLARGINE, |
||||
| 546 | 25028616 |
GB |
64 | 2 |
Dry mouth, Blood glucose increased, |
||||
RAMIPRIL, |
||||
| 547 | 25028687 |
US |
60 | 1 |
Blood glucose increased, Influenza, Glycosylated haemoglobin increased, Product storage error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 548 | 25028692 |
US |
1 | |
Food poisoning, Blood glucose increased, |
||||
TIRZEPATIDE, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 549 | 25028726 |
CO |
71 | 2 |
Blood glucose increased, Urinary tract infection, Off label use, |
||||
ROTIGOTINE, AMANTADINE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, FUROSEMIDE, DIMENHYDRINATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PROPRANOLOL HYDROCHLORIDE, |
||||
| 550 | 25028739 |
US |
25 | 2 |
Diarrhoea, Nausea, Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, DULAGLUTIDE, |
||||
| 551 | 25028879 |
CA |
||
Disability, Seizure, Extra dose administered, Blood glucose increased, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 552 | 25028948 |
US |
44 | 1 |
Limb injury, Staphylococcal infection, Blood glucose increased, |
||||
INSULIN ASPART, AMOXICILLIN, |
||||
| 553 | 25025699 |
US |
1 | |
Visual impairment, Blood glucose increased, |
||||
LIRAGLUTIDE, DULAGLUTIDE, |
||||
| 554 | 25025725 |
US |
2 | |
Vision blurred, Tremor, Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 555 | 25025728 |
US |
16 | 2 |
Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 556 | 25025729 |
US |
1 | |
Toothache, Nervousness, Insomnia, Fatigue, Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 557 | 25025822 |
US |
2 | |
COVID-19, Skin discolouration, Blood glucose increased, Product communication issue, |
||||
LIRAGLUTIDE, |
||||
| 558 | 25025856 |
US |
2 | |
Visual impairment, Blood glucose increased, |
||||
LIRAGLUTIDE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 559 | 25025870 |
US |
65 | 1 |
Neck pain, Blood glucose increased, Diarrhoea, |
||||
SEMAGLUTIDE, LIRAGLUTIDE, |
||||
| 560 | 25025883 |
US |
56 | 2 |
Vision blurred, Weight increased, Blood glucose increased, Device issue, Device defective, |
||||
LIRAGLUTIDE, |
||||
| 561 | 25025885 |
US |
74 | 2 |
Vision blurred, Nausea, Blood glucose increased, Multiple use of single-use product, Wrong technique in product usage process, Off label use, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 562 | 25025886 |
US |
||
Weight increased, Blood glucose increased, |
||||
INSULIN DETEMIR, LIRAGLUTIDE, |
||||
| 563 | 25025889 |
US |
69 | 2 |
Visual impairment, Colonoscopy, Oral discomfort, Chapped lips, Oral discomfort, Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 564 | 25025897 |
US |
2 | |
Unevaluable event, Memory impairment, Blood glucose increased, Wrong technique in device usage process, Product label confusion, |
||||
LIRAGLUTIDE, |
||||
| 565 | 25025898 |
US |
1 | |
Weight decreased, Blood glucose increased, Hyperglycaemia, Product quality issue, Injection site bruising, |
||||
LIRAGLUTIDE, |
||||
| 566 | 25025942 |
US |
2 | |
Ill-defined disorder, Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 567 | 25026050 |
US |
72 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, INSULIN GLARGINE, |
||||
| 568 | 25026162 |
US |
52 | 2 |
Product dose omission issue, Paraesthesia, Blood glucose increased, Fatigue, Vision blurred, Pain, Hypoaesthesia, |
||||
INSULIN HUMAN, |
||||
| 569 | 25026522 |
US |
56 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 570 | 25026700 |
US |
74 | 1 |
Blood glucose increased, Product dispensing error, |
||||
INSULIN GLARGINE AND LIXISENATIDE, INSULIN ASPART, |
||||
| 571 | 25026706 |
US |
61 | 1 |
Blood glucose increased, Off label use, Product dispensing error, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 572 | 25026786 |
US |
68 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 573 | 25026860 |
US |
63 | 2 |
Blood glucose increased, Device mechanical issue, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 574 | 25026916 |
US |
76 | 2 |
Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 575 | 25026940 |
US |
66 | 1 |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 576 | 25027161 |
US |
80 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 577 | 25027238 |
US |
65 | 1 |
Blood glucose increased, |
||||
DUPILUMAB, |
||||
| 578 | 25027412 |
US |
1 | |
Hypoglycaemia, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 579 | 25027466 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 580 | 25027562 |
US |
75 | 1 |
Weight decreased, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 581 | 25027563 |
US |
57 | 2 |
Eye disorder, Blood glucose increased, Exposure via skin contact, Accidental exposure to product, |
||||
INSULIN GLARGINE, |
||||
| 582 | 25027613 |
US |
69 | 2 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN ASPART, |
||||
| 583 | 25027682 |
US |
80 | 2 |
Blood glucose increased, |
||||
DUPILUMAB, |
||||
| 584 | 25027723 |
US |
61 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 585 | 25027782 |
US |
32 | 2 |
Blood glucose increased, Incorrect dose administered by device, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 586 | 25027817 |
US |
2 | |
Blood glucose increased, Incorrect dose administered, Device leakage, |
||||
INSULIN GLARGINE, |
||||
| 587 | 25027899 |
US |
81 | 1 |
Blood glucose increased, |
||||
DUPILUMAB, |
||||
| 588 | 25027924 |
US |
49 | |
Blood glucose increased, |
||||
INSULIN GLARGINE, DULAGLUTIDE, |
||||
| 589 | 25028011 |
US |
69 | 2 |
Blood glucose increased, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 590 | 25028349 |
US |
70 | 1 |
Blood glucose increased, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, SEMAGLUTIDE, |
||||
| 591 | 25031737 |
62 | 2 | |
Blood glucose increased, |
||||
FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, |
||||
| 592 | 25021068 |
US |
49 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 593 | 25021279 |
CO |
60 | 1 |
Blood glucose increased, Intestinal obstruction, |
||||
ROTIGOTINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, |
||||
| 594 | 25021292 |
US |
78 | 1 |
Blood glucose increased, Drug ineffective, |
||||
FARICIMAB, INSULIN ASPART, APIXABAN, LISINOPRIL, SIMVASTATIN, MEMANTINE, MEMANTINE HYDROCHLORIDE, DONEPEZIL HYDROCHLORIDE, AMLODIPINE, FUROSEMIDE, CLONAZEPAM, LATANOPROST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PANTOPRAZOLE, SERTRALINE, PROMETHAZINE, HYDROXYZINE, |
||||
| 595 | 25021330 |
US |
||
Blood glucose increased, Blood pressure decreased, Feeling abnormal, Dizziness, Back pain, Neck pain, Headache, Fatigue, |
||||
DAPAGLIFLOZIN, |
||||
| 596 | 25021387 |
US |
63 | 2 |
Accidental underdose, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 597 | 25021657 |
US |
1 | |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 598 | 25021996 |
US |
49 | |
Incorrect dose administered, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 599 | 25022093 |
DE |
1 | |
Pituitary gland operation, Blood glucose increased, Lipid metabolism disorder, |
||||
SOMAPACITAN-BECO, SOMAPACITAN-BECO, |
||||
| 600 | 25022167 |
US |
70 | 2 |
Systemic lupus erythematosus, Butterfly rash, Blood pressure increased, Blood bilirubin increased, Weight decreased, Arthralgia, Condition aggravated, Blood glucose increased, Condition aggravated, Headache, Blood glucose decreased, Drug effect less than expected, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28